MARKET

RARE

RARE

Ultragenyx Pharm
NASDAQ
50.85
+1.24
+2.50%
After Hours: 51.20 +0.35 +0.69% 17:52 06/02 EDT
OPEN
51.04
PREV CLOSE
49.61
HIGH
51.47
LOW
49.90
VOLUME
501.05K
TURNOVER
0
52 WEEK HIGH
68.68
52 WEEK LOW
33.36
MARKET CAP
3.60B
P/E (TTM)
-4.9585
1D
5D
1M
3M
1Y
5Y
Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and QuidelOrtho (QDEL)
TipRanks · 1d ago
Ultragenyx: A Promising Bet On Rare Genetic Disorder Therapies
Seeking Alpha · 5d ago
Navigating Mereo BioPharma's Future: Risky Proposition Despite Strides In Rare Disease Treatment
Seeking Alpha · 5d ago
Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE), Genmab (GMAB) and Fusion Pharmaceuticals (FUSN)
TipRanks · 05/23 15:50
Ultragenyx: Despite OI Trial Doubts, This Is A Robust Rare Disease Company
Seeking Alpha · 05/22 12:53
Ultragenyx Pharmaceutical (RARE) Receives a Buy from Robert W. Baird
TipRanks · 05/21 13:25
Ultragenyx Pharmaceutical (RARE) Gets a Buy from SVB Securities
TipRanks · 05/21 13:25
Ultragenyx Pharm: Report of proposed sale of securities
Press release · 05/20 19:16
More
About RARE
Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company. The Company is focused on the identification, acquisition, development, and commercialization of novel products for the treatment of serious rare and ultra-rare genetic diseases. The Company’s therapies and clinical-stage pipeline consist of four product categories, such as biologics, small molecules, gene therapy, and nucleic acid product candidates. The Company’s four approved product candidates include Crysvita (burosumab) is for the treatment of X-linked hypophosphatemia (XLH), and tumor-induced osteomalacia (TIO); Mepsevii (vestronidase alfa) is for the treatment of mucopolysaccharidosis VII (MPSVII) or Sly Syndrome; Dojolvi (triheptanoin) is for the treatment of long-chain fatty acid oxidation disorders or LC-FAOD, and Evkeeza (evinacumab) is for the treatment of homozygous familial hypercholesterolemia (HoFH). The Company's clinical product candidates include DTX401, DTX301, UX143, GTX-102, UX701 and UX053.

Webull offers kinds of Ultragenyx Pharmaceutical Inc stock information, including NASDAQ:RARE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RARE stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading RARE stock methods without spending real money on the virtual paper trading platform.